TrkB is proposed to function as a key regulator of oncogenesis and tumor progression in a variety of human cancers, including lung [7], breast [8], pancreatic [27], stomach [28], colon [28,29], prostate [30], and ovarian cancer [31]. This evidence concerns the gene NTRK2 and ovarian carcinoma.